study
BioNTech, DualityBio say ADC had ‘modest’ benefit in breast cancer study
BioPharma Dive · 1d ago
AstraZeneca
Medicine & Biotech · covered by 3 outlets this week · tracked since 2026-10-27
Press: 2 mainstream 1 specialist outlet-days
Coverage
AstraZeneca Readies New Portfolio of Targeted Cancer Therapies
WSJ Health · 2d ago
China’s rapid human trials draw western drugmakers — and safety concerns
Financial Times Health · 4d ago